New SEC Form D filing

Mangrove Therapeutics Inc., 2026-07-31

A new SEC Form D private-offering notice from Sacramento, CA, a $5,000,000 filer-stated offering target in Biotech. The source filing is one click away.

What this filing says

Mangrove Therapeutics Inc. Verified via SEC Form D

Biotechnology company developing first in class RNA based therapies targeting a master regulator of inflammation in polygenic inflammatory diseases.

Filed 2026-07-31Filed to raise $5,000,000First money in 2026-07-21Raised so far $2,455,000HQ (as filed) Sacramento, CASector Biotech web-verified against the company’s own siteStage (inferred) EarlyCall status Call-ready
Source linked the Form D on EDGAR↗Named in the filing 3 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.

Other Form D filings from the same week

each with its own page and its own EDGAR source